Your body needs lysine every day to build proteins, but it cannot make a single molecule of it on its own. Everything circulating in your blood came from what you ate, how well you absorbed it, and how your body is using it. Testing lysine offers a window into whether that chain is holding up.
Research is starting to connect circulating lysine to more than just nutrition. Levels shift in severe illness, inherited metabolic conditions, and patterns associated with future metabolic disease. This is a newer, research-oriented measurement without standardized clinical cutpoints, but tracking it can give you an early, exploratory view of your amino acid status.
Lysine is one of nine essential amino acids, meaning you have to get it from dietary protein. Inside your cells it goes into building new proteins, helping your body absorb calcium for bone strength, supporting the formation of collagen (the scaffold protein in skin, tendons, and vessels), and serving as a starting material for carnitine, a molecule that helps shuttle fats into your cells' energy-making compartments.
Lysine is also the site of chemical tags that influence how genes are switched on and off, and how proteins carry out their jobs. That makes it a hub for both structural work and fine-tuned metabolic regulation. When intake is low, or when illness pulls hard on your amino acid pool, circulating lysine is one of the amino acids that tends to shift first.
In a large Mediterranean study of adults at high cardiovascular risk, people with higher baseline plasma lysine had a meaningfully higher chance of developing type 2 diabetes (long-term high blood sugar). For each standard step up in lysine, the risk of developing diabetes was about 26 percent higher, after accounting for age, sex, body weight, smoking, physical activity, blood pressure, and lipid levels.
This does not mean lysine causes diabetes. It suggests lysine is one piece of a broader amino acid pattern that shows up when insulin is working less efficiently. A full-year Mediterranean diet alone did not significantly change lysine levels, so this is closer to a trait marker than an easily nudged one.
Your body converts some lysine into a chemically modified form called trimethyllysine, or TML. In a study of about 2,140 adults undergoing cardiac evaluation, people in the top quarter of TML had roughly 2.4 times the risk of a major cardiac event over three years, and about 2.9 times the risk of dying from any cause over five years, compared with those in the bottom quarter. The link held after adjusting for cholesterol, blood pressure, diabetes, smoking, and inflammation.
TML is a related but different measurement than the lysine this test quantifies. It is made from lysine inside your body, so lysine biology shapes TML production, but a high TML reading and a high lysine reading are not the same thing. The TML evidence is useful context for why lysine metabolism matters for heart health, not direct evidence that your lysine number predicts heart attacks.
In children admitted to intensive care with sepsis (a severe, body-wide response to infection), plasma lysine drops sharply at the onset of illness and drifts back toward normal by day seven as they recover. Lysine moves inversely with C-reactive protein (a blood marker that rises during inflammation), which fits the pattern of an amino acid pool being heavily drawn on to fuel immune response and tissue repair.
In a group of 237 malnourished adult inpatients followed in the EFFORT nutrition trial, low lysine was not associated with higher 30-day or 180-day death rates after adjusting for other illness factors, while low methionine (another essential amino acid) was. So in adults, lysine can reflect acute stress on your system without being the sharpest predictor of short-term outcomes.
You will notice the findings do not line up into a simple higher-is-better or lower-is-better story. Higher lysine is linked with future diabetes risk, yet lower lysine shows up in acute illness and in plant-based diets where intake may be limited. The way to hold both is to treat lysine as a pattern indicator rather than a good-number or bad-number marker. A high lysine in a metabolically unwell person reflects something different from a mid-range lysine in a healthy person, and a sudden drop during illness reflects something different from chronically low lysine from inadequate intake. The value of testing is seeing your own pattern over time, in context with the rest of your metabolic picture.
A rare inherited condition called lysinuric protein intolerance causes the body to lose lysine in the urine because the transporter that normally pulls it back into circulation is broken. The result is low plasma lysine despite adequate diet, along with feeding difficulties, growth problems, and buildup of ammonia in the blood. Another inherited condition, hyperlysinemia, leads to persistently high lysine due to an enzyme defect. Both are uncommon, but they are the clearest examples of what persistent, unexplained lysine shifts can signal.
There are no universally agreed clinical cutpoints for plasma lysine in adults. Published reference intervals vary by lab, assay method, and the population sampled. The values below are research-reported, illustrative orientation only. Your lab will likely use different numbers, possibly in different units, so compare your results within the same lab over time rather than treating any single threshold as absolute.
| Context | Research-Reported Range | What It Suggests |
|---|---|---|
| Typical control adults (targeted metabolomics study) | Around 167 nmol/mL on average | A working midpoint for healthy adults in one research cohort |
| Adults treated with the immunosuppressant tacrolimus | Around 201 nmol/mL on average | Modestly higher than controls, a non-significant trend in one study |
| Older-adult dietary lysine needs | About 32 to 54 mg per kg of body weight per day of intake | Intake target, not a blood level; women over 70 may need more than men or younger-old women |
Because this is a research-oriented measurement, anchor your interpretation to your own baseline rather than a population average. A single reading outside a published range is not a diagnosis. A sustained trend in your own data is more meaningful.
Plasma lysine responds to what you ate in the hours before the draw, to recent illness, and to how much protein-building your body is doing day to day. That means one reading is a snapshot, not a verdict. Getting a baseline, retesting in three to six months if you are changing your diet or recovering from something, and then rechecking at least once a year gives you a trajectory you can actually interpret.
The value of serial testing is sharpest here because the marker is research-grade. You are essentially building your own reference interval, and you will have your own data to compare against as the science matures. A level that sits in the same zone across three testing occasions means more than any single number.
An unexpected reading, high or low, is worth a second test in the same lab after a consistent overnight fast before making decisions. If your result stays abnormal, the next step is pattern matching rather than chasing the lysine number in isolation. A full amino acid panel tells you whether the shift is isolated to lysine or part of a broader signature. Companion labs that help you interpret the result include:
A medical geneticist or metabolic specialist is the right referral if the pattern suggests an inherited condition. A registered dietitian is the right resource if the pattern points to protein nutrition, particularly if you follow a plant-based diet.
A few factors can distort a single lysine reading without reflecting any real change in your long-term status. The most important to know:
Evidence-backed interventions that affect your Lysine level
Lysine is best interpreted alongside these tests.